ImmunityBio, Inc. (IBRX)
11.55
+1.72
(+17.50%)
USD |
NASDAQ |
Feb 24, 16:00
11.95
+0.40
(+3.46%)
After-Hours: 05:57
ImmunityBio Shareholders Equity (Annual) : -500.47M for Dec. 31, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Novavax, Inc. | -623.84M |
| Krystal Biotech, Inc. | 1.220B |
| Rapt Therapeutics, Inc. | 189.90M |
| Moderna, Inc. | 8.65B |
| Corcept Therapeutics, Inc. | 679.59M |